Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone.
Colorectal cancer is a leading cause of mortality worldwide. Resistance to therapy is common and often results in patients succumbing to the disease. The mechanisms of resistance are poorly understood. Cells basically have two possibilities to survive a treatment with potentially apoptosis-inducing...
Main Authors: | David M Baron, Ulrike Kaindl, Verena J Haudek-Prinz, Editha Bayer, Clemens Röhrl, Christopher Gerner, Brigitte Marian |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4263530?pdf=render |
Similar Items
-
The Role of Ciglitazone Inhibits Tumor Growth in Human Glioblastoma Multiforme
by: Huai-Yun Hu, et al.
Published: (2012) -
The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
by: Marie-Laure Plissonnier, et al.
Published: (2011-01-01) -
Effect of ciglitazone on adipogenic transdifferentiation of bovine
skeletal muscle satellite cells
by: Junfang Zhang, et al.
Published: (2021-07-01) -
Ciglitazone—a human PPARγ agonist—disrupts dorsoventral patterning in zebrafish
by: Vanessa Cheng, et al.
Published: (2019-11-01) -
PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells
by: Chien-Da Huang, et al.
Published: (2014-08-01)